The Latest

• June 02, 2020

  By Jet Encila

  Emergent Bio, US Gov't Enter Into $628 Million COVID-19 Drug Deal

  The deal also includes an $85.5 million investment to boost Emergent's non-viral vaccine manufacturing capability.

  

  The deal also includes an $85.5 million investment to boost Emergent's non-viral vaccine manufacturing capability.